Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 390

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 390
---
 will not be unreasonably conditioned, withheld, delayed or denied) or as required by applicable law:

| • |     | except in connection with any Extension Amendment (as defined in the Merger Agreement), amend, modify or supplement its organizational documents; |

| • |     | pay, declare or promise to pay any dividends or other distributions with respect to its capital stock, share capital or other equity interests; |

| • |     | reclassify, split, combine or subdivide any of its capital stock or securities convertible or exchangeable into or exercisable for any shares of its capital stock; |

| • |     | obtain or incur any indebtedness (other than to finance Denali’s expenses) which indebtedness shall not exceed (i) $250,000 in the aggregate or (ii) in the event that an Extension Amendment (as defined in the Merger Agreement) is in effect, $1,750,000; |

| • |     | merge or consolidate with any other entity or acquire any corporation, partnership, association or other business entity or organization or division thereof; |

| • |     | make any change in its accounting principles other than in accordance with the applicable accounting policies; |

| • |     | extend any loans other than travel or other expense advances to employees in the ordinary course of business or with the principal amount not exceeding $25,000; |

| • |     | make or change any material tax election or change any annual tax accounting periods; |

| • |     | enter into, renew, modify or revise any contract with any current or former affiliate of Denali; |

| • |     | create any subsidiary; |

| • |     | except as previously disclosed to Semnur, enter into any new contract with any broker, finder, investment banker or other person or entity under which such person or entity is or will be entitled to any brokerage fee, finders’ fee or other commission in connection with the transactions contemplated by the Merger Agreement; |

| • |     | except as previously disclosed to Semnur, issue, redeem, repurchase or otherwise acquire any capital stock, share capital, membership interests or other securities, or issue any securities exchangeable for or convertible into any share or any shares of its capital stock, or enter into any agreement with respect to the voting of its capital stock or share capital; |

| • |     | withdraw, amend, modify or supplement the pre-signing certificate of merger to eliminate legacy subsidiaries of Denali; or |

| •